Fortress Biotech (FBIO) Short-term Investments (2014 - 2020)

Fortress Biotech's Short-term Investments history runs 5 years deep, the most recent figure standing at $15.0 million for Q4 2019.

• In Q4 2019, Short-term Investments fell 14.79% year-over-year to $15.0 million; the TTM figure through Dec 2019 stood at $15.0 million (down 14.79% YoY), while the FY2019 annual figure was $15.0 million, down 14.79% from the prior year.
• Short-term Investments for Q4 2019 stood at $15.0 million, roughly flat from $14.9 million in the prior quarter.
• The five-year high for Short-term Investments was $44.1 million in Q3 2017, with the low at $5.0 million in Q2 2019.
• The 4-year median for Short-term Investments is $20.0 million (2015), against an average of $23.7 million.
• The sharpest annual moves came in 2015 and 2019: Short-term Investments jumped 76728.85% in 2015, then tumbled 86.37% in 2019.
• Fortress Biotech's Short-term Investments stood at $40.0 million in 2015, then retreated by 9.88% to $36.0 million in 2017, then sank by 51.1% to $17.6 million in 2018, then retreated by 14.79% to $15.0 million in 2019.
• Business Quant data shows FBIO's Short-term Investments at $15.0 million in Q4 2019, $14.9 million in Q3 2019, and $5.0 million in Q2 2019.